NZ719350A - Injectable parasiticidal formulations of levamisole and macrocyclic lactones - Google Patents
Injectable parasiticidal formulations of levamisole and macrocyclic lactonesInfo
- Publication number
- NZ719350A NZ719350A NZ719350A NZ71935011A NZ719350A NZ 719350 A NZ719350 A NZ 719350A NZ 719350 A NZ719350 A NZ 719350A NZ 71935011 A NZ71935011 A NZ 71935011A NZ 719350 A NZ719350 A NZ 719350A
- Authority
- NZ
- New Zealand
- Prior art keywords
- levamisole
- injection
- macrocyclic lactone
- formulation
- water
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33388210P | 2010-05-12 | 2010-05-12 | |
NZ70365711 | 2011-05-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ719350A true NZ719350A (en) | 2017-10-27 |
Family
ID=60320555
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ719350A NZ719350A (en) | 2010-05-12 | 2011-05-12 | Injectable parasiticidal formulations of levamisole and macrocyclic lactones |
Country Status (1)
Country | Link |
---|---|
NZ (1) | NZ719350A (en) |
-
2011
- 2011-05-12 NZ NZ719350A patent/NZ719350A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ603699A (en) | Injectable parasiticidal formulations of levamisole and macrocyclic lactones | |
WO2009048959A8 (en) | Rapid acting injectable insulin compositions | |
NZ604026A (en) | Injectable flowable composition comprising buprenorphine | |
CY1122838T1 (en) | TOPICAL COMPOSITIONS INCLUDING FIPRONIL AND PERMETHRIN AND METHODS OF USE | |
CR20140541A (en) | NON-WATER THERMAL PHARMACEUTICAL FORMULATIONS | |
CA2864118A1 (en) | Formulations of bendamustine | |
CL2012003350A1 (en) | Injectable pharmaceutical controlled release composition comprising risperidone, a copolymer of lactic and glycolic acid, a water-miscible solvent, a viscosity and a ratio of specific solvent / drug and drug / polymer masses; pharmaceutical kit; and use to treat schizophrenia or bipolar disorders. | |
AR051969A1 (en) | METHODS AND COMPOSITIONS THAT USE IMMUNOMODULATING COMPOUNDS FOR THE TREATMENT AND MANAGEMENT OF INJURIES OF THE CENTRAL NERVOUS SYSTEM | |
RU2006146610A (en) | PHARMACEUTICAL COMPOSITIONS, INCLUDING POLYETHYLENE GLYCOL, POSSESSING MOLECULAR MASS, EQUAL LESS THAN 600 DALTON | |
WO2010041141A3 (en) | Oil-based foamable carriers and formulations | |
WO2008153611A3 (en) | Sustained delivery formulations of risperidone compounds | |
SV2008003106A (en) | STABLE PHARMACEUTICAL COMPOSITION CONTAINING DOCETAXEL AND A METHOD FOR MANUFACTURING IT | |
WO2012092528A8 (en) | Treatment of erectile dysfunction and other indications | |
WO2005007122A3 (en) | Polymer stabilization | |
AR071533A1 (en) | IMPROVED MICROEMULSION WITH A WIDE RANGE OF APPLICATION | |
WO2009139589A3 (en) | Transnasal anticonvulsive pharmaceutical composition comprising poorly soluble anticonvulsant | |
NZ612185A (en) | Topical combination formulations of macrocyclic lactones with synthetic pyrethroids | |
WO2011126839A3 (en) | Compositions and methods for improved retention of a pharmaceutical composition at a local administration site | |
WO2011019326A3 (en) | Solubility and stability enchancing pharmaceutical formulation | |
WO2015048757A3 (en) | Foam formulations and apparatus for delivery | |
WO2011081865A3 (en) | Formulations and methods for raising the flash points of volatile organic solvents | |
WO2011112922A3 (en) | Co-crystals and pharmaceutical formulations comprising the same | |
WO2011076209A3 (en) | Pharmaceutical composition comprising solvent mixture and a vitamin d derivative or analogue | |
PH12019500466A1 (en) | Sustained-release buprenorphine formulations | |
NZ719350A (en) | Injectable parasiticidal formulations of levamisole and macrocyclic lactones |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ASS | Change of ownership |
Owner name: MERIAL, INC., US Effective date: 20161124 |
|
PSEA | Patent sealed | ||
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 12 MAY 2018 BY FB RICE PTY LTD Effective date: 20180131 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 12 MAY 2019 BY COMPUTER PACKAGES INC Effective date: 20180501 |
|
ASS | Change of ownership |
Owner name: BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC., US Effective date: 20190328 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 12 MAY 2020 BY COMPUTER PACKAGES INC Effective date: 20190418 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 12 MAY 2021 BY COMPUTER PACKAGES INC Effective date: 20200418 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 12 MAY 2022 BY DENNEMEYER + CO. Effective date: 20210503 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 12 MAY 2023 BY DENNEMEYER + CO. S.A.R.L. Effective date: 20220502 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 12 MAY 2024 BY DENNEMEYER + CO Effective date: 20230501 |